Crespo A - Search Results

1

Asialofetuin liposome-mediated human alpha1-antitrypsin gene transfer in vivo results in stationary long-term gene expression.

Dasí F, Benet M, Crespo J, Crespo A, Aliño SF. Dasí F, et al. Among authors: crespo a, crespo j. J Mol Med (Berl). 2001 May;79(4):205-12. doi: 10.1007/s001090000185. J Mol Med (Berl). 2001. PMID: 11409712

2

Expression of human alpha 1-antitrypsin in mouse after in vivo gene transfer to hepatocytes by small liposomes.

Aliño SF, Crespo J, Bobadilla M, Lejarreta M, Blaya C, Crespo A. Aliño SF, et al. Among authors: crespo a, crespo j. Biochem Biophys Res Commun. 1994 Nov 15;204(3):1023-30. doi: 10.1006/bbrc.1994.2565. Biochem Biophys Res Commun. 1994. PMID: 7980573

3

Long-term expression of the human alpha1-antitrypsin gene in mice employing anionic and cationic liposome vectors.

Crepso J, Blaya C, Crespo A, Aliño SF. Crepso J, et al. Among authors: crespo a. Biochem Pharmacol. 1996 May 17;51(10):1309-14. doi: 10.1016/0006-2952(96)00038-x. Biochem Pharmacol. 1996. PMID: 8787546

4

Long-term therapeutic levels of human alpha-1 antitrypsin in plasma after hydrodynamic injection of nonviral DNA.

Aliño SF, Crespo A, Dasí F. Aliño SF, et al. Among authors: crespo a. Gene Ther. 2003 Sep;10(19):1672-9. doi: 10.1038/sj.gt.3302065. Gene Ther. 2003. PMID: 12923566

5

Hydrodynamic liver gene transfer mechanism involves transient sinusoidal blood stasis and massive hepatocyte endocytic vesicles.

Crespo A, Peydró A, Dasí F, Benet M, Calvete JJ, Revert F, Aliño SF. Crespo A, et al. Gene Ther. 2005 Jun;12(11):927-35. doi: 10.1038/sj.gt.3302469. Gene Ther. 2005. PMID: 15729372

6

Pharmacodynamic approach to study the gene transfer process employing non-viral vectors.

Aliño SF, Escrig E, Revert F, Guillem VM, Crespo A. Aliño SF, et al. Among authors: crespo a. Biochem Pharmacol. 2000 Dec 15;60(12):1845-53. doi: 10.1016/s0006-2952(00)00503-7. Biochem Pharmacol. 2000. PMID: 11108800

7

Stability of PEI-DNA and DOTAP-DNA complexes: effect of alkaline pH, heparin and serum.

Moret I, Esteban Peris J, Guillem VM, Benet M, Revert F, Dasí F, Crespo A, Aliño SF. Moret I, et al. Among authors: crespo a. J Control Release. 2001 Sep 11;76(1-2):169-81. doi: 10.1016/s0168-3659(01)00415-1. J Control Release. 2001. PMID: 11532322

8

Anti-interleukin 4 antibody and indomethacin synergistic effect on B16 melanoma tumor progression.

Blaya C, Crespo J, Crespo A, Aliño SF. Blaya C, et al. Among authors: crespo a, crespo j. J Pharmacol Exp Ther. 1996 Nov;279(2):472-7. J Pharmacol Exp Ther. 1996. PMID: 8930148

9

Complete tumor prevention by engineered tumor cell vaccines employing nonviral vectors.

Moret-Tatay I, Díaz J, Marco FM, Crespo A, Aliño SF. Moret-Tatay I, et al. Among authors: crespo a. Cancer Gene Ther. 2003 Dec;10(12):887-97. doi: 10.1038/sj.cgt.7700646. Cancer Gene Ther. 2003. PMID: 14712315

10

Effect of the protein kinase inhibitors, 1-(5-isoquinolinylsulfonyl)-2-methylpiperazine H-7 and N-(2-[methylamino]ethyl)-5-isoquinoline-sulfonamide H-8 on Lewis lung carcinoma tumor progression.

Blaya C, Crespo J, Crespo A, Aliño SF. Blaya C, et al. Among authors: crespo a, crespo j. Eur J Pharmacol. 1998 Jul 31;354(1):99-104. doi: 10.1016/s0014-2999(98)00434-8. Eur J Pharmacol. 1998. PMID: 9726636

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

563 results

Search Page

Filters